Summary The potential use of tumour-specific T-lymphocytes loaded with ricin in cell targeting experiments was investigated. Moloney-murine sarcoma virus (M-MSV)-specific T-lymphocytes, obtained in mass mixed leucocyte-tumour cell culture (MLTC) and a M-MSV-specific cytotoxic T-lymphocyte (CTL) clone, were incubated with 125I-labelled ricin in order to evaluate toxin uptake and release. The internalized ricin (4.5 x 10-"7 mol and 6.5 x 10-17 mol per 102 MLTC and CTL clone cells, respectively) was released rapidly during the first 30min following treatment, and at a constant but slower rate over the next few hours. The cytotoxic activity of ricin-treated cells evaluated against antigen-related target cells, in a short term incubation "Cr release assay, was unaffected during the first 30min after treatment but decreased with time over the next few hours. However, the growth of antigen related as well as of unrelated tumour cells was strongly inhibited by the addition of ricin-treated cells to the culture system, thus indicating that released ricin is toxic for untreated target cells.
Lymphocytes in vitro have been shown to have specificity both of binding to and killing of antigenic target cells (Cerottini & Brunner, 1974) . It is usually assumed that these properties reflect the existence of a mechanism by which the immunological apparatus can discharge its function in the living animal. As far as cytotoxic T-lymphocytes (CTL) are concerned, recognition of target cells and the capability to kill them in vitro require cell-to-cell contact (Martz, 1975) , although it should be noted that there are probably a number of indirect effects due to locally diffusible factors that can contribute to cytotoxicity.
It is believed that one cytotoxic cell can kill one or more target cells following contact in the appropriate milieu (Zagury et al., 1975) . This is an important finding when the efficiency of killing is taken into account.
In a different context, the plant toxin ricin is profoundly cytotoxic in that one molecule is thought to be sufficient to kill a eukaryotic cell (Eiklid et al., 1980) . It is also believed that many if not all nucleated cells can internalise ricin and recycle it to the exterior of the cell without loss of its toxicity (McIntosh et al., 1984) . By means of such toxin-carrying capacity it is possible to extrapolate that up to five thousand cells can be killed with the toxin associated with a single cell (McIntosh et al., 1984) .
Taking, on the one hand, the phenomenon of T-cell cytotoxicity and, on the other, toxin carriers it was deemed feasible to attempt to devise super-killer cells which were capable of specificity of localisation because of their target cell recognitive capacity and wholesale killing due to their prior contact with appropriate amounts of ricin.
The principle involved has already been tested using normal lymphocytes which, having been loaded with ricin, were injected into rats (Sparshott et al., 1985) . It was found subsequently that damage to the recipient animals was most evident in those parts of the peripheral lymphoid system to which the injected lymphocytes had migrated.
The aim of the present study was to ascertain whether lymphocytes loaded with ricin could be cytotoxic in vitro and, if they could, whether they could have any effects on tumours in vivo which carried the target antigens. To this end Moloney-murine sarcoma virus (M-MSV)-specific Tlymphocytes, obtained in mass mixed leucocyte-tumour cell culture (MLTC) and a virus-specific CTL clone were preincubated with ricin prior to injection into mice carrying M-MSV-induced tumours. Previous studies (Collavo et al., 1980; Engers et al., 1984) have shown that T-lymphocytes per se are highly efficient in this experimental system. The present experiments were to determine whether T-lymphocyte anti-tumour activity was maintained if the lymphocytes concerned were in addition carriers of ricin.
Materials and Methods
Mice Inbred C57BL/6 (B6) 6-8 week old mice were purchased from the Charles River Laboratories (Calco Como, Italy). Mice were treated with 5 Gy whole body irradiation (2.5Gymin-1, linear accelerator, 8MV, MEL, SL 75) and injected, on the same day with M-MSV extract.
Tumour induction M-MSV cell free extract (0.05 ml), the titre of which on 3T3/FL cells was 1 x 107 focus forming units ml -1, were injected into the rear footpad of sublethally irradiated mice. Three to 5 days later local tumours developed which were measured daily using calipers. Cell cultures (a) Secondary CTL were generated in vitro in an MLTC system as previously described (Collavo et al., 1978 (Collavo et al., 1978) . After 4h of incubation, the plates were centrifuged, 0.1 ml supernatant removed for counting and the percentage specific 51Cr release calculated as follows: 100 (experimental release -spontaneous release) (maximum release -spontaneous release)
Tumour cell proliferation assay Cultures containing ricin-treated effector cells and 5 x 103 tumour target cells were incubated, in triplicate, at different effector to target cell ratios in microplates containing 200 jul medium. After 48 h the cultures were pulsed with 1 pCi 3HTdR/well (NEN) and 8h later harvested on filter paper using a cell harvester (Skatron AS, Norway). The radioactivity was measured in a beta scintillation spectrometer (Beckman Instruments Inc., Irvine, California). Control cultures included tumour cells incubated in medium alone or in medium containing free-ricin at different concentrations.
Lymphocyte injection in tumour-bearing mice Cells treated with lOg of ricin were resuspended in medium supplemented with 3% FCS and kept for 30min at 37°C during which time -25% of the internalised ricin is released. Thereafter the cells were washed, maintained in cold medium and injected i.v. into tumour bearing mice. Control mice were injected only with toxin or with the same dose of untreated cells.
Assessment of the distribution of transferred cells MLTC or CTL clone cells (107) were labelled with 100 jul 51Cr and at the same time loaded with 10 g of ricin.
After 1 h in a CO2 incubator, the cells were repeatedly washed, as reported above. In one experiment, cells carrying 125I-labelled ricin, according to the protocol described above, were used. Labelled cells (2 x 106 cells in 0.2 ml medium) were injected i.v. into tumour bearing sublethally irradiated mice. Animals were killed either 1 or 6 h following injection. Their organs were removed and counted in a gamma scintillation counter. Recovery from each organ was calculated as the percentage of total radioactivity injected.
Results
Ricin uptake and release by antigen-specific T-lymphocytes Preliminary experiments were carried out to evaluate ricin uptake by antigen specific T-lymphocytes. MLTC cells and CTL clones were incubated for 1 h at 37°C with 10 g of 1251-labelled ricin, then washed repeatedly in medium containing 0.1 M lactose to remove toxin bound to the cell surface. This procedure evaluates toxin internalized by pinocytosis (Sandvig et al., 1978) . Using 1251-labelled ricin, the amount of toxin taken up by 102 cells was calculated to be 4.5 x 10 -7mol (2.9 pg) ricin when MLTC cells were used. When cells from the CTL clone were employed the ricin incorporation was 6.5 x 10 -17mol, 4.2pg 10 -2 cells. The extent of ricin binding can differ considerably from cell type to cell type (Sandvig et al., 1978) but in the present instance it should be noted that the higher ricin uptake was in the larger cells. (LI) The medium was replaced by fresh medium every hour and the total amount of radioactive material released to the combined medium was calculated at each time point; (-) the medium was not changed and the radioactivity released was measured at each time point. In all instances the coefficients of variation were less than 10%. Sandvig & Olsnes (1979) observed that HeLa cells excrete internalized ricin rapidly during the first 30 min, and then at a slower rate. Figure 1 (panel a) shows that MLTC cells also release 1251-labelled ricin more rapidly initially than at later times. Similar results were obtained using CTL clones. It should be noted that less than 80% of the material obtained in the medium is not precipitated by TCA, thus indicating that only a small fraction of released ricin has undergone degradation during its period of internalisation (data not shown).
In a second series of similar experiments the external medium of the cells was replaced every hour with an equal quantity of fresh medium, and the radioactivity released by MLTC cells measured as before. Under these conditions, the rate of late toxin release was similar to that obtained in cultures where cells were left in the same medium (Figure 1,  panel b) . Moreover, at the end of the incubation MLTC cells contained the same amount of 1251-labelled ricin, regardless of the culture conditions in which they were maintained.
On the basis of these experiments in vitro three things emerge. Firstly that toxin release occurs, secondly the rate of release is constant after the first 30min and thirdly that after the first hour the rate of release is not affected by the concentration of ricin in the external medium. It may be that the concentration of ricin in the external medium does not affect the rate of release of ricin during the first hour also, but the experiments presented provide no information on that score.
Cytotoxic activity of ricin-treated antigen-specific T-lymphocytes Virus-specific cytotoxic cells obtained in MLTC and CTL clones were pretreated with ricin washed repeatedly as above, allowed to stand for a further 30min at 37°C, washed again, and, after various time intervals, tested against relevant target cells. As shown in Figure 2 , 30min after these treatments the lytic activity of the effector cells was comparable to that of untreated controls. However, lytic activity decreased with time over the next few hours, and at 8 h little if any cytotoxicity was detected in either cell type.
Transfer of ricin-toxicity by antigen-specific T-lymphocytes To study whether the ricin released by cytotoxic lymphocytes maintains its toxicity for other cells, different numbers of ricin- (Figure 3) . The inhibition of antigen-related MBL-2 leukaemia cell growth was greater than that of antigen unrelated P815 cells. This finding is only in part due to specific lytic activity, since untreated MLTC cells also cause growth inhibition (Figure 3, panel  a) , and, in part, to the higher susceptibility of MBL-2 cells to the effect of free ricin (Figure 3, panel b) .
Distribution of ricin-treated T-lymphocytes in vivo
Numerous studies indicate that T-lymphocytes maintained in long term culture are trapped mainly in the lungs, and liver of the animals in which they are transferred (Dailey et al., 1982; Carroll et al., 1983 "Cr-labelled MLTC cells were injected i.v. into sublethally irradiated mice, which were killed I or 6 h later. After 1 h no differences in localization between ricin-treated and untreated MLTC cells were observed (Figure 4 ) broadly in accord with the more extensive results of Sparshott and her colleagues. Most of the radioactivity was as expected found in the lungs, and to a lower extent in the liver. Moreover, the percentage recovery of injected radioactivity in mice receiving ricin-treated and untreated MLTC cells was similar (43% and 47%, respectively). After 6h, there was a decline in radioactivity in the lungs, accompanied by an increase in the liver; this change in the pattern of cell distribution was more pronounced when ricin-treated MLTC cells were transferred. Similar results were obtained using CTL clone cells whose recovery was evaluated 6 h after injection. In this instance, the recovery was 7% in the lungs and 29% in the liver in mice injected with ricin-treated cells and 20% in the lung and 21% in the liver in mice receiving untreated cloned cells (data not shown). One group of mice was also injected with MLTC cells pre-treated with 125I-labelled ricin. In these mice after 6h a high recovery of radiolabel in lungs and liver (6% and 12%, respectively), comparable to that of mice injected with 51Cr-labelled cells, was observed. In addition, 13% of the radioactivity was detected in the gastrointestinal tract (data not shown). This is probably due to toxin freed from cells rather than cell migration because the same distribution is found when toxin alone is injected. These results also indicate that free ricin is eliminated faster than ricin interalized in the cells, since only 11% of the injected toxin was recovered after 6h in mice receiving ricin alone, while 48% of the radioactivity was recovered at this time interval in mice receiving labelled cells.
Antitumour activity of ricin-treated T-lymphocyte transfer
We previously observed that the transfer of virus-specific Tlymphocytes i.v. into syngeneic immunodepressed mice can prevent the development of the autochthonous tumours which otherwise develop following simultaneous injection of M-MSV at a distant site (Collavo et al., 1980 ). This tumour model was chosen to study the effect of adoptive transfer of ricin-treated virus-specific T-lymphocytes, in view of its high sensitivity to CTL activity and because tumour size is readily evaluated.
Since several studies have demonstrated the antitumour properties of ricin (Lin et al., 1970; Fodstad et al., 1976 Fodstad et al., , 1977 Fodstad & Pihl, 1978) , preliminary experiments were carried out to evaluate its effect on M-MSV-induced tumour growth. Tumour-bearing irradiated mice, receiving M-MSV in the rear footpad 5 to 6 days previously, were injected i.v. with various ricin doses; dose-response curves of tumour growth in control and in ricin-treated mice show that tumour growth slows down only when the near lethal dose of 20 ng of ricin was injected ( Figure 5) ; 20% of mice died in 6 to 7 days.
To evaluate the therapeutic effect of ricin-treated virusspecific T-lymphocytes, MLTC cells were pre-incubated with 10 Mg of toxin for I h at 37°C. After repeated washing in lactose-containing medium, the cells were further incubated at 37°C for 30 min in order to eliminate ricin which is rapidly released during this period. Sublethally irradiated mice bearing M-MSV-induced tumours received an i.v. inoculum of ricin-treated MLTC cells. Mice injected with M-MSV only, or with untreated virus-specific MLTC cells, were used as controls. Following the injection of 1 or 2 x 106 ricin-treated MLTC cells the tumour stopped growing for several days, and then grew again at a slower rate (Figure 6 ).
Transfer of 2 x 106 untreated MLTC cells had no protective effect. It should however be noted that injection of 107 untreated MLTC cells can be protective. At the cell dose used, all mice survived for more than I month, and eventually died following tumour enlargement. When 4 x 106 treated MLTC cells were injected all mice died within 4 to 5 days due to ricin toxicity (data not shown).
In order to evaluate whether the protective effect exerted by the transferred cells was specific for M-MSV antigens, 2 x 106 lymphocytes sensitized in mixed lymphocyte culture against H-2d alloantigens were pretreated with 10/.tg of ricin and injected i.v. into tumour bearing irradiated mice. We observed that ricin-treated alloreactive cells did not inhibit M-MSV tumour growth, while virus-specific MLTC cells were efficient (Figure 6 ).
It was then considered that tumour growth inhibition might result from a combined effect of CTL lytic activity and ricin anti-tumour activity. Therefore, virus-specific lymphocytes, obtained in MLTC, were pretreated with anti Lyt 2 monoclonal antibodies and C to eliminate Lyt 2+ cytotoxic cells; the remaining Lyt 1+2-enriched cell population, which lacked lytic activity against MBL-2 lymphoma cells, was pretreated with ricin and injected i.v. into tumour bearing recipient mice. As shown in Figure 7 , the transfer of the non-cytolytic T-cell fraction conferred a temporary protection provided that cells were pretreated with ricin; untreated cells were again inefficient.
Recent results indicate that it is possible to cure mice of M-MSV-induced tumours by transferring M-MSV-specific CTL clones Cerundolo et al., 1984) ; 5. however, a protective effect is achieved only by using large (2 x 107) cell doses. It was thus considered interesting to study whether low numbers of ricin-treated cloned cells might be effective. We observed that the injection of 0.5 x 106 cells from a M-MSV-specific CTL clone pretreated with ricin was sufficient to inhibit tumour growth for six days ( Figure 8) ; transfer of higher cell doses (2 x 106) caused rapid death of the recipient mice presumably due to ricin toxicity (data not shown).
Discussion
The initial purpose of this work was to ascertain whether CTL that had been exposed to ricin were still capable of exercising their lytic activity. The answer is yes but not for long.
Ricin is an inhibitor of ribosomal protein synthesis via the agency of its A-chain. It is believed that the B-chain of the toxin binds the holotoxin molecule to the surface of target cells prior to its internalisation partly if not entirely in coated-pit vesicles (Olsnes & Pihl, 1982) . Subsequently at least one A-chain is required to enter the cytoplasm if cell death is to occur. It is known that the process of internalisation of holotoxin can take place in minutes and also that when the cells concerned have been exposed to high concentrations of toxin, inhibition of protein synthesis can be complete in two hours (Barbieri & Stirpe, 1982) . It is about 48 h after this that the plasma membrane of the poisoned cell disintegrates, but there is of course loss of a number of cell functions prior to this final stage. The relatively rapid drop off in the capacity of lyse target cells, seen in the present study, is not surprising since CTL activity is impaired by numerous protein synthesis inhibitors (Henney, 1973) . The small difference observed between the cloned cytotoxic cells and the MLTC cells as far as the rate of decline of cytotoxic potential after contact with ricin would require confirmation before its further discussion were worthwhile.
In vitro the difference between the killing effect of ricin carrying cells and those cytotoxic in their own right was evident but not large, nor perhaps could it expected to be. The conditions in which cytotoxic assays are enacted at least in the present study mean that the target cells are the only ones of which the growth inhibition can be recorded. Any ricin released from the effector cells will also have toxicity for all cells alike in the culture. Seen in this light, any selectivity of binding possessed by the effector cells was, in the circumstances of the present experiments, not likely to result in any particularly non-random distribution of the carried toxin. In this regard, ricin released by MLTC cells was able to inhibit proliferation of antigen-related MBL-2 and unrelated P815 leukaemic cells.
The results in vivo merit more detailed consideration. There the tumour target cells represent a relatively small part of the host animal into which the cytotoxic cells, ricincarrying or not, were injected. The specific cytotoxicity of toxin is only that imparted to it by the effector cells. The preliminary results in the present study show, as did the more thorough studies of Sparshott and her colleagues (1985) , using normal lymphocytes, that ricin carrying cells can localise in a similar manner to cells not carrying ricin at least for a short time. It should be noted that the sites of principal localisation in the present studies were not the sites of tumour growth although it must be remarked that it would be appropriate to repeat the localisation studies in tumour-bearing animals. In parenthesis it should be noted that attempts to demonstrate tumour localisation by injected cytotoxic cells (e.g. Carroll et al., 1983; De Jong et al., 1985) have only ever shown 2-4% of the cells injected at the site of the tumour even in circumstances in which a therapeutic effect has been observed. In the present study it was shown that ricin is lost from the effector cells in vitro at a steady rate and that there is a steady decline in the capability specifically to kill. It is reasonable to assume that similar timing pertains in vivo. In such circumstances the demonstration of a degree of tumour inhibition without death of the host animal is encouraging.
Clearly the experiments could further be refined to optimise the effects seen. The strategy to be adopted could depend on the use of larger numbers of cells carrying smaller burdens of ricin. Such studies will be undertaken but it is apparent from the present experiments that the margin for manoeuvre between enhancement of specific cytotoxicity by ricin carrying and killing the animals due to release of toxin in inappropriate places is small.
